Vaccination News Home Page            Scandals            subscribe Vaccination NewsLetter

http://www.pediatrics.org/cgi/content/abstract/111/5/964

Full Text of this Article Reprint (PDF) Version of this Article Email this article to a friend P3Rs: Submit a response to this article Similar articles found in: Pediatrics Online PubMed PubMed Citation Search Medline for articles by: Byington, C. L. || Pavia, A. T. Alert me when: new articles cite this article   Download to Citation Manager

Collections under which this article appears: Infectious Disease & Immunity

Related AAP Red Book topics:     Escherichia coli and Other Gram-negative Bacilli (Septicemia and Meningitis in Neonates)

PEDIATRICS Vol. 111 No. 5 May 2003, pp. 964-968

 

Serious Bacterial Infections in Febrile Infants Younger Than 90 Days of Age: The Importance of Ampicillin-Resistant Pathogens

Carrie L. Byington, MD^*,, Kristine K. Rittichier, MD, Kathlene E. Bassett, MD, Heidi Castillo, MD^*, Tiffany S. Glasgow, MD^*, Judy Daly, PhD^¶ and Andrew T. Pavia, MD

^* University of Utah Divisions of General Pediatrics
Pediatric Infectious Diseases
Pediatric Emergency Medicine
^¶ PCMC Microbiology Laboratory, Salt Lake City, Utah

Background. Intrapartum antibiotic prophylaxis against group B Streptococcus (GBS) has reduced the occurrence of serious bacterial infections (SBI) in young infants caused by GBS. Recommendations for initial antibiotic therapy for the febrile infant 1 to 90 days old were developed when infections with GBS were common and antibiotic resistance was rare.

Objective. To document the pathogens responsible for SBI in recent years in febrile infants 1 to 90 days old and the antibiotic susceptibility of these organisms.

Methods. The results of bacterial cultures from infants 1 to 90 days old evaluated for fever at Primary Children’s Medical Center in Salt Lake City, Utah, between July 1999 and April 2002 were analyzed. Antibiotic susceptibility profiles were collected and patient records were reviewed to determine if initial antibiotic therapy was changed following the identification of the organism.

Results. Of 1298 febrile infants enrolled from the Primary Children’s Medical Center emergency department, 105 (8%) had SBI. The mean age of the infants with SBI was 39 days (range 2–82 days) and 2 (2%) were <7 days. SBI included urinary tract infection (UTI; 67%), bacteremia (16%), bacteremia and UTI (6%), bacteremia and meningitis (5%), meningitis (2%), abscess (2%), meningitis and UTI (1%), and meningitis and gastroenteritis (1%). Eighty-three (79%) of 105 episodes of SBI were caused by Gram-negative bacteria, including 92% of UTI, 54% of bacteremia, and 44% of meningitis cases. The most common pathogen was Escherichia coli (61%). Other Gram-negative pathogens were responsible for 19% of SBI. Staphylococcus aureus was the most common Gram-positive pathogen, causing 8% of SBI. GBS accounted for 6% of SBI.

Of the 105 pathogens, 56 (53%) were resistant to ampicillin. Of the pathogens causing meningitis, UTI, and bacteremia, 78%, 53%, and 50%, respectively, were resistant to ampicillin. Antibiotic therapy was changed in 54% of cases of SBI following identification of the organism.

Conclusions. In Utah, ampicillin-resistant Gram-negative bacteria are the most common cause of SBI in febrile infants <90 days old. This finding impacts antibiotic selection, especially in cases of meningitis. Local surveillance of pathogens and antibiotic susceptibility patterns is critical to determine appropriate antibiotic therapy.

Key Words: fever • infant • serious bacterial infection • ampicillin • antibiotic resistance

Abbreviations: GBS, group B Streptococcus • SBI, serious bacterial infection • UTI, urinary tract infection • ESBL, extended spectrum ß-lactamases • ampC, ampC ß-lactamases • PCMC, Primary Children’s Medical Center • ED, emergency department • CSF, cerebrospinal fluid

Received for publication Aug 28, 2002; accepted Nov 12, 2002.

Copyright © 2003 by the American Academy of Pediatrics. [Disclaimer]

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.